EU Rare Disease Policy Needs To Help Revive Abandoned Candidates & Repurpose Existing Drugs

 
• By Eliza Slawther
  
Abandoned house
Sponsors could revisit abandoned orphan drug candidates • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Health Technology Assessment

More from Market Access